RBC Capital analyst Douglas Miehm maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Outperfor

Ligand Pharmaceuticals NASDAQ: LGND reported second-quarter 2026 results marked by higher royalty re

Ligand Pharmaceuticals Incorporated (LGND) Q2 2026 Earnings Call Transcript

HC Wainwright & Co. analyst Joseph Pantginis maintains Ligand Pharmaceuticals (NASDAQ:LGND) w

Ligand Pharmaceuticals (NASDAQ:LGND) raises FY2026 Adj EPS guidance from $8.50-$9.50 to $9.00-$9.50

Ligand Pharmaceuticals (NASDAQ:LGND) has outperformed the market over the past 15 years by 14.91% on

Arrowstreet Capital Limited Partnership reduced its position in Ligand Pharmaceuticals Incorporated

Oppenheimer analyst Leland Gershell reiterates Ligand Pharmaceuticals (NASDAQ:LGND) with a Outper

Ashford Capital Management Inc. reduced its position in shares of Ligand Pharmaceuticals Incorporate

JUPITER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND)

Citigroup analyst Yigal Nochomovitz reinstates Ligand Pharmaceuticals (NASDAQ:LGND) with a Buy an

Wall Street analysts are making bold moves on Tuesday, shaking up ratings for some of the biggest na

RBC Capital analyst Douglas Miehm maintains Ligand Pharmaceuticals (NASDAQ:LGND) with a Outperfor

Agenus Inc. (AGEN) stock experiences profit-taking on Tuesday after a 111% surge. Discover the lates

EMERYVILLE, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation today announced that

Acquisition adds seven  commercial products including VABYSMO® (faricimab-svoa), OJEMDA™ (tovorafeni

Agenus ($AGEN) stock rockets over 111% following stellar 3-year colorectal cancer data and a $340M f

The S&P 500 is up 10.3% YTD, and Wall Street is convinced the markets have more room to run, particu

Ligand Pharmaceuticals has delivered exceptional long-term returns, rising from ~$86 to nearly $300

Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the pro

Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the pro

Opportunistic capital raise with proceeds used to enhance financial flexibility  A portion of the pr

Kozarich sold 2,501 common shares. This transaction represented 5.65% of direct holdings.

JUPITER, Fla., June 10, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND)

5,000 shares were sold for a total transaction value of ~$1.14 million on June 1, 2026, at a weighte

JUPITER, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) t

Ligand Pharmaceuticals Incorporated will acquire XOMA Royalty Corporation for $39.00 per share in ca

Ligand Pharmaceuticals NASDAQ: LGND reported first-quarter 2026 results that management said reflect

First quarter performance driven by strong year-over-year royalty revenue growth of  56% Reaffirms P

U.S. stocks were lower, Dow Jones fell 0.1% on Monday. XOMA shares rose on Ligand's plans to acq

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a

Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quar

  Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings fo

  On Tuesday, 951 companies hit new 52-week lows.

  On Friday, 1043 companies hit new 52-week lows.

  Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report qu

    On Wednesday, 348 companies hit new 52-week lows.

  Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report q

Here's a roundup of top developments in the biotech space over the last 24 hours:

  Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for it